Skip to main content
Erschienen in: Calcified Tissue International 3/2007

01.03.2007

Influence of Estradiol on Vascular Endothelial Growth Factor Expression in Bone: A Study in Göttingen Miniature Pigs and Human Osteoblasts

verfasst von: T. Pufe, H. Claassen, K. E. Scholz-Ahrens, D. Varoga, W. Drescher, A. T. M. Franke, C. Wruck, W. Petersen, C. Cellarius, J. Schrezenmeir, C.-C. Glüer

Erschienen in: Calcified Tissue International | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

Ovariectomy (OVX) in animal models is an accepted method to simulate postmenopausal osteoprosis. Vascular endothelial growth factor (VEGF) has been recently shown to play an important role during endochondral bone formation, hypertrophic cartilage remodeling, ossification, and angiogenesis. We hypothesized that reduced VEGF expression in bone contributes to OVX-induced bone loss and tested it in a miniature pig model and in vitro using human osteoblasts. Seventeen primiparous sows (Göttingen miniature pigs) were allocated to two experimental groups when they were 30 months old: a control group (n = 9) and an OVX group (n = 8). After 15 months, VEGF levels in lumbar vertebrae were measured by enzyme-linked immunosorbent assay and verified by Western blot analysis. VEGF and its receptor (VEGFR) were localized by immunohistochemistry. Expression of VEGF mRNA was analyzed by real-time reverse-transcription polymerase chain reaction. Differently sulfated glycosaminoglycans were localized in subchondral bone histochemically. Osteoblasts were immunopositive for VEGF. VEGF concentration in the vertebra was 27% lower in OVX miniature pigs. VEGFR-2 could be immunostained on osteoblasts. VEGF mRNA and protein were detectable in the lumbar vertebrae of all animals. In subchondral trabecular bone of OVX animals, significantly more islands of mineralized cartilage containing chondroitin 4- and 6-sulfate or keratan sulfate occurred compared to the control group. The occurrence of remnants of mineralized cartilage in subchondral bone of the OVX group may be caused by a delayed bone turnover due to low VEGF levels. In vitro experiments revealed an increase of VEGF in the supernatant of osteoblasts after incubation with estradiol. In conclusion, estrogen seems to be a key factor for regulation of VEGF expression in bone. Loss of VEGF due to menopause may be a reason for reduction of bone density.
Literatur
2.
Zurück zum Zitat Ham KD, Carlson CS (2004) Effects of estrogen replacement therapy on bone turnover in subchondral bone and epiphyseal metaphyseal cancellous bone of ovariectomized cynomolgus monkeys. J Bone Miner Res 19:823–829PubMedCrossRef Ham KD, Carlson CS (2004) Effects of estrogen replacement therapy on bone turnover in subchondral bone and epiphyseal metaphyseal cancellous bone of ovariectomized cynomolgus monkeys. J Bone Miner Res 19:823–829PubMedCrossRef
3.
Zurück zum Zitat Tanizawa T, Yamaguchi A, Uchiyama Y, Miyaura C, Ikeda T, Ejiri S, Nagal Y, Yamato H, Murayama H, Sato M, Nakamura T (2000) Reduction of bone formation and elevated bone resorption in ovariectomized rats with special reference to acute inflammation. Bone 26:43–53PubMedCrossRef Tanizawa T, Yamaguchi A, Uchiyama Y, Miyaura C, Ikeda T, Ejiri S, Nagal Y, Yamato H, Murayama H, Sato M, Nakamura T (2000) Reduction of bone formation and elevated bone resorption in ovariectomized rats with special reference to acute inflammation. Bone 26:43–53PubMedCrossRef
4.
Zurück zum Zitat Baldock PA, Morris HA, Moore RJ, Need AG, Durbridge TC (1998) Prepubertal oophorectomy limits the accumulation of cancellous bone in the femur of growing rats with long-term effects on metaphyseal bone architecture. Calcif Tissue Int 62:244–249PubMedCrossRef Baldock PA, Morris HA, Moore RJ, Need AG, Durbridge TC (1998) Prepubertal oophorectomy limits the accumulation of cancellous bone in the femur of growing rats with long-term effects on metaphyseal bone architecture. Calcif Tissue Int 62:244–249PubMedCrossRef
5.
Zurück zum Zitat Tanaka M, Toyooka E, Kohno S, Ozawa H, Ejiri S (2003) Long-term changes in trabecular structure of aged rat alveolar bone after ovariectomy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:495–502PubMedCrossRef Tanaka M, Toyooka E, Kohno S, Ozawa H, Ejiri S (2003) Long-term changes in trabecular structure of aged rat alveolar bone after ovariectomy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:495–502PubMedCrossRef
6.
Zurück zum Zitat Cai DJ, Zhao Y, Glasier J, Cullen D, Barnes S, Turner CH, Wastney M, Weaver CM (2005) Comparative effect of soy protein, soy isoflavones, and 17ß-estradiol on bone metabolism in adult ovariectomized rats. Bone Miner Res 20:828–839CrossRef Cai DJ, Zhao Y, Glasier J, Cullen D, Barnes S, Turner CH, Wastney M, Weaver CM (2005) Comparative effect of soy protein, soy isoflavones, and 17ß-estradiol on bone metabolism in adult ovariectomized rats. Bone Miner Res 20:828–839CrossRef
7.
Zurück zum Zitat Frost HM (1987) The mechanostat: a proposed pathogenetic mechanism of osteoporosis and the bone mass effects of mechanical and nonmechanical agaents. Bone Miner 2:73–85PubMed Frost HM (1987) The mechanostat: a proposed pathogenetic mechanism of osteoporosis and the bone mass effects of mechanical and nonmechanical agaents. Bone Miner 2:73–85PubMed
8.
9.
Zurück zum Zitat Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5:623–628PubMedCrossRef Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5:623–628PubMedCrossRef
10.
Zurück zum Zitat Pufe T, Scholz-Ahrens KE, Franke ATM, Petersen W, Mentlein R, Varoga D, Tillmann B, Schrezenmeir J, Glüer CC (2003) The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: evaluation in a minipig model. Bone 33:869–876PubMedCrossRef Pufe T, Scholz-Ahrens KE, Franke ATM, Petersen W, Mentlein R, Varoga D, Tillmann B, Schrezenmeir J, Glüer CC (2003) The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: evaluation in a minipig model. Bone 33:869–876PubMedCrossRef
11.
Zurück zum Zitat Kang DH, Yu ES, Yoon KI, Johnson R (2004) The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am J Pathol 164:679–688PubMed Kang DH, Yu ES, Yoon KI, Johnson R (2004) The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am J Pathol 164:679–688PubMed
12.
Zurück zum Zitat Sugino N, Kashida S, Karube-Harada A, Takiguchi S, Kato H (2002) Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy. Reproduction 123:379–387PubMedCrossRef Sugino N, Kashida S, Karube-Harada A, Takiguchi S, Kato H (2002) Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy. Reproduction 123:379–387PubMedCrossRef
13.
Zurück zum Zitat Albrecht ED, Babischkin JS, Lidor Y, Anderson LD, Udoff LC, Pepe GJ (2003) Effect of estrogen on angiogenesis in co-cultures of human endometrial cells and microvascular endothelial cells. Hum Reprod 18:2039–2047PubMedCrossRef Albrecht ED, Babischkin JS, Lidor Y, Anderson LD, Udoff LC, Pepe GJ (2003) Effect of estrogen on angiogenesis in co-cultures of human endometrial cells and microvascular endothelial cells. Hum Reprod 18:2039–2047PubMedCrossRef
14.
Zurück zum Zitat Nakagawa Y, Fujimoto J, Tamaya T (2004) Placental growth by the estrogen-dependent angiogenic factors, vascular endothelial growth factor and basic fibroblast growth factor, throughout gestation. Gynecol Endocrinol 19:259–266PubMedCrossRef Nakagawa Y, Fujimoto J, Tamaya T (2004) Placental growth by the estrogen-dependent angiogenic factors, vascular endothelial growth factor and basic fibroblast growth factor, throughout gestation. Gynecol Endocrinol 19:259–266PubMedCrossRef
15.
Zurück zum Zitat Thomsen M, von Strachwitz B, Loew M, Cotta H, Kirsch S, Schunk O, Kubein-Meesenburg D (1997) The Göttingen minipig as an animal model in hip endoprosthesis. Anatomy, anesthesia, operation results. Z Orthop Ihre Grenzgeb 135:58–62PubMedCrossRef Thomsen M, von Strachwitz B, Loew M, Cotta H, Kirsch S, Schunk O, Kubein-Meesenburg D (1997) The Göttingen minipig as an animal model in hip endoprosthesis. Anatomy, anesthesia, operation results. Z Orthop Ihre Grenzgeb 135:58–62PubMedCrossRef
16.
Zurück zum Zitat Scholz-Ahrens KE, Delling G, Jungblut PW, Kallweit E, Barth CA (1996) Effect of ovarectomy on bone histology and plasma parameters of bone metabolism in nulliparous and multiparous sows. Z Ernährungswiss 35:13–21PubMedCrossRef Scholz-Ahrens KE, Delling G, Jungblut PW, Kallweit E, Barth CA (1996) Effect of ovarectomy on bone histology and plasma parameters of bone metabolism in nulliparous and multiparous sows. Z Ernährungswiss 35:13–21PubMedCrossRef
17.
Zurück zum Zitat Scholz-Ahrens KE, Barth CA, Kann P, Lüttges J, Roberts H, Schrezenmeir J (1998) Ovariectomy induced bone loss in the minipig - an animal model for postmenopausal osteoporosis. Exp Clin Endocrinol Diabetes 106:S9 Scholz-Ahrens KE, Barth CA, Kann P, Lüttges J, Roberts H, Schrezenmeir J (1998) Ovariectomy induced bone loss in the minipig - an animal model for postmenopausal osteoporosis. Exp Clin Endocrinol Diabetes 106:S9
18.
Zurück zum Zitat Scholz-Ahrens KE, Barth CA, Kann P, Lüttges J, Roberts H, Schrezenmeir J (1998) Impact of dietary calcium on the effect of ovariectomy on bone density in minipigs. Osteoporos Int 8(suppl 3):S101 Scholz-Ahrens KE, Barth CA, Kann P, Lüttges J, Roberts H, Schrezenmeir J (1998) Impact of dietary calcium on the effect of ovariectomy on bone density in minipigs. Osteoporos Int 8(suppl 3):S101
19.
Zurück zum Zitat Scholz-Ahrens KE, Delling G, Stampa B, Barkmann R, Timm W, Schrezenmeir J, Glüer CC (2000) Bone mineral density and trabecular structure in steroid-induced osteoporosis in minipigs. J Bone Miner Res 15(suppl 1):S542 Scholz-Ahrens KE, Delling G, Stampa B, Barkmann R, Timm W, Schrezenmeir J, Glüer CC (2000) Bone mineral density and trabecular structure in steroid-induced osteoporosis in minipigs. J Bone Miner Res 15(suppl 1):S542
20.
Zurück zum Zitat Pufe T, Petersen W, Tillmann B, Mentlein R (2001) The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum 44:1082–1088PubMedCrossRef Pufe T, Petersen W, Tillmann B, Mentlein R (2001) The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum 44:1082–1088PubMedCrossRef
21.
Zurück zum Zitat Trueta J (1963) The role of vessels in osteogenesis. J Bone Joint Surg 45:402–418 Trueta J (1963) The role of vessels in osteogenesis. J Bone Joint Surg 45:402–418
22.
Zurück zum Zitat Carlevaro MF, Cermeli S, Cancedda R, Descalzi-Cancedda F (2000) Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 113:59–69PubMed Carlevaro MF, Cermeli S, Cancedda R, Descalzi-Cancedda F (2000) Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 113:59–69PubMed
23.
Zurück zum Zitat Petersen W, Tsokos M, Pufe T (2002) Expression of the VEGF splice variants 121 and 165 in hypertrophic chondrocytes of the human growth plate and epiphyseal cartilage. J Anat 201:153–157PubMedCrossRef Petersen W, Tsokos M, Pufe T (2002) Expression of the VEGF splice variants 121 and 165 in hypertrophic chondrocytes of the human growth plate and epiphyseal cartilage. J Anat 201:153–157PubMedCrossRef
24.
Zurück zum Zitat Pufe T, Wildemann B, Petersen W, Mentlein R, Raschke M, Schmidmaier G (2002) Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor (VEGF) in the time flow of fracture healing: a study in rat. Cell Tissue Res 309:387–392PubMedCrossRef Pufe T, Wildemann B, Petersen W, Mentlein R, Raschke M, Schmidmaier G (2002) Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor (VEGF) in the time flow of fracture healing: a study in rat. Cell Tissue Res 309:387–392PubMedCrossRef
25.
Zurück zum Zitat Hyder SM, Huang JC, Nawaz Z, Boettger-Tong H, Makela S, Chiappetta C, Stancel GM (2000) Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environ Health Perspect 208:785–790CrossRef Hyder SM, Huang JC, Nawaz Z, Boettger-Tong H, Makela S, Chiappetta C, Stancel GM (2000) Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environ Health Perspect 208:785–790CrossRef
26.
Zurück zum Zitat Guenther HL, Fleisch H, Soregente N (1986) Endothelial cells in culture synthesize a potent bone cell active mitogen. Endocrinology 119:193–201PubMedCrossRef Guenther HL, Fleisch H, Soregente N (1986) Endothelial cells in culture synthesize a potent bone cell active mitogen. Endocrinology 119:193–201PubMedCrossRef
27.
Zurück zum Zitat Zaidi M, Alam ASMT, Bax BE, Shankar VS, Bax CMR, Gill JS, Pazianas M, Huang CLH, Sahinoglu T, Moonga BS, Stevens CR, Blake DR (1993) Role of endothelial cell in osteoclast control: new perspectives. Bone 14:97–102PubMedCrossRef Zaidi M, Alam ASMT, Bax BE, Shankar VS, Bax CMR, Gill JS, Pazianas M, Huang CLH, Sahinoglu T, Moonga BS, Stevens CR, Blake DR (1993) Role of endothelial cell in osteoclast control: new perspectives. Bone 14:97–102PubMedCrossRef
28.
Zurück zum Zitat Miyaura C, Kusano K, Masuzawa T, Chaki O, Onoe Y, Aoyagi M, Sasaki T, Tamura T, Koishihara Y, Ohsugi Y (1995) Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6. J Bone Miner Res 10:1365–1373PubMedCrossRef Miyaura C, Kusano K, Masuzawa T, Chaki O, Onoe Y, Aoyagi M, Sasaki T, Tamura T, Koishihara Y, Ohsugi Y (1995) Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6. J Bone Miner Res 10:1365–1373PubMedCrossRef
29.
Zurück zum Zitat Lean JM, Davies JT, Fuller K, Jagger CJ, Kirstein B, Partington GA, Urry ZL, Chambers TJ (2003) A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 112:915–923PubMedCrossRef Lean JM, Davies JT, Fuller K, Jagger CJ, Kirstein B, Partington GA, Urry ZL, Chambers TJ (2003) A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 112:915–923PubMedCrossRef
30.
Zurück zum Zitat Zhu G, Wang H, Xu P (2001) Relationship between serum 1,25-dihydroxyvitamin D and bone loss in postmenopausal women. Zhonghua Yi Xue Za Zhi (Taipei) 81:1443–1446 Zhu G, Wang H, Xu P (2001) Relationship between serum 1,25-dihydroxyvitamin D and bone loss in postmenopausal women. Zhonghua Yi Xue Za Zhi (Taipei) 81:1443–1446
31.
Zurück zum Zitat Liel Y, Shany S, Smirnoff P, Schwartz B (1999) Estrogen increases 1,25-dihydroxyvitamin D receptors expression and bioresponse in the rat duodenal mucosa. Endocrinology 140:280–285PubMedCrossRef Liel Y, Shany S, Smirnoff P, Schwartz B (1999) Estrogen increases 1,25-dihydroxyvitamin D receptors expression and bioresponse in the rat duodenal mucosa. Endocrinology 140:280–285PubMedCrossRef
32.
Zurück zum Zitat Filipovic B, Sosic-Jurjevic B, Nestorovic N, Manojlovic, Stojanoski M, Kostic N, Milosevic V, Sekulic M (2003) The thyroid C cells of ovariectomized rats treated with estradiol. Histochem Cell Biol 120:409–414PubMedCrossRef Filipovic B, Sosic-Jurjevic B, Nestorovic N, Manojlovic, Stojanoski M, Kostic N, Milosevic V, Sekulic M (2003) The thyroid C cells of ovariectomized rats treated with estradiol. Histochem Cell Biol 120:409–414PubMedCrossRef
33.
Zurück zum Zitat Masiukiewicz US, Mitnick M, Gulanski BI, Insogna KL (2002) Evidence that the IL-6/IL-6 soluble receptor cytokine system plays a role in the increased skeletal sensitivity to PTH in estrogen-deficient women. J Clin Endocrinol Metab 87:2892–2898PubMedCrossRef Masiukiewicz US, Mitnick M, Gulanski BI, Insogna KL (2002) Evidence that the IL-6/IL-6 soluble receptor cytokine system plays a role in the increased skeletal sensitivity to PTH in estrogen-deficient women. J Clin Endocrinol Metab 87:2892–2898PubMedCrossRef
34.
Zurück zum Zitat Martinez P, Esbrit P, Rodrigo A, Alvarez-Arroyo MV, Martinez ME (2002) Age-related changes in parathyroid hormone-related protein and vascular endothelial growth factor in human osteoblastic cells. Osteoporos Int 13:874–881PubMedCrossRef Martinez P, Esbrit P, Rodrigo A, Alvarez-Arroyo MV, Martinez ME (2002) Age-related changes in parathyroid hormone-related protein and vascular endothelial growth factor in human osteoblastic cells. Osteoporos Int 13:874–881PubMedCrossRef
35.
Zurück zum Zitat Esbrit P, Alvarez-Arroyo MV, De Miguel F, Martin O, Martinez ME, Caramelo C (2000) C-terminal parathyroid hormone-related protein increases vascular endothelial growth factor in human osteoblastic cells. J Am Soc Nephrol 11:1085–1092PubMed Esbrit P, Alvarez-Arroyo MV, De Miguel F, Martin O, Martinez ME, Caramelo C (2000) C-terminal parathyroid hormone-related protein increases vascular endothelial growth factor in human osteoblastic cells. J Am Soc Nephrol 11:1085–1092PubMed
36.
Zurück zum Zitat Schlaeppi JM, Gutzwiller S, Finkenzeller G, Fournier B (1997) 1,25-Dihydroxyvitamin D3 induces the expression of vascular endothelial growth factor in osteoblastic cells. Endocr Res 23:213–229PubMedCrossRef Schlaeppi JM, Gutzwiller S, Finkenzeller G, Fournier B (1997) 1,25-Dihydroxyvitamin D3 induces the expression of vascular endothelial growth factor in osteoblastic cells. Endocr Res 23:213–229PubMedCrossRef
37.
Zurück zum Zitat Wang DS, Yamazaki K, Nohtomi K, Shizume K, Ohsumi K, Shibuya M, Demurs H, Sato K (1996) Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells. J Bone Miner Res 11:472–479PubMed Wang DS, Yamazaki K, Nohtomi K, Shizume K, Ohsumi K, Shibuya M, Demurs H, Sato K (1996) Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells. J Bone Miner Res 11:472–479PubMed
38.
Zurück zum Zitat Huang RY, Miller LM, Carlson CS, Chance MR (2002) Characterization of bone mineral composition in the proximal tibia of cynomolgus monkeys: effect of ovariectomy and nandrolone decanoate treatment. Bone 30:492–497PubMedCrossRef Huang RY, Miller LM, Carlson CS, Chance MR (2002) Characterization of bone mineral composition in the proximal tibia of cynomolgus monkeys: effect of ovariectomy and nandrolone decanoate treatment. Bone 30:492–497PubMedCrossRef
39.
Zurück zum Zitat Turner RT, Evans GL, Wakley GK (1994) Reduced chondroclast differentiation results in increased cancellous bone volume in estrogen-treated growing rats. Endocrinology 134:461–466PubMedCrossRef Turner RT, Evans GL, Wakley GK (1994) Reduced chondroclast differentiation results in increased cancellous bone volume in estrogen-treated growing rats. Endocrinology 134:461–466PubMedCrossRef
Metadaten
Titel
Influence of Estradiol on Vascular Endothelial Growth Factor Expression in Bone: A Study in Göttingen Miniature Pigs and Human Osteoblasts
verfasst von
T. Pufe
H. Claassen
K. E. Scholz-Ahrens
D. Varoga
W. Drescher
A. T. M. Franke
C. Wruck
W. Petersen
C. Cellarius
J. Schrezenmeir
C.-C. Glüer
Publikationsdatum
01.03.2007
Erschienen in
Calcified Tissue International / Ausgabe 3/2007
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-006-0275-0

Weitere Artikel der Ausgabe 3/2007

Calcified Tissue International 3/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.